By Jessica Hamzelou Misfolded proteins linked to Parkinson’s disease have been seen moving between the brain and gutmolekuul.be / Alamy Parkinson’s disease may start in the gut and travel to the brain – but it can also spread from the brain to the gut, according to findings in baboons. Misfolded proteins thought to trigger brain… Read More »
A new study using a roundworm model of Parkinson’s disease found that a probiotic bacterium could prevent, and in some cases reverse, toxic protein buildup. Misfolded alpha-synuclein proteins in the brain are the hallmark sign of Parkinson’s disease. Many experts believe that these toxic protein clumps lead to the progressive loss of brain cells that… Read More »
FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease Print this page TOKYO–(BUSINESS WIRE)– August 28, 2019 — Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Nourianz (istradefylline) for use as adjunctive treatment… Read More »
Acadia Pharmaceuticals is taking Parkinson’s disease education on the road in a partnership with the Michael J. Fox Foundation. The “Parkinson’s IQ + You” series will traverse the country through this year and next, connecting with local community resources in each city. The sessions, staffed by healthcare providers, physical and speech therapists, clinical trial teams… Read More »
It’s been known for a long time that Parkinson’s disease is a condition that arises in the brain. Certain nerve cells in the brain begin to break down, and levels of dopamine, a neurotransmitter, drop, resulting in coordination difficulties, muscle stiffness, changes in speech, and the tremor that is the disease’s signature symptom. But now… Read More »